Best Telehealth Clinics in North Carolina (2026)

North Carolina's telehealth framework is governed by N.C.G.S. Chapter 90, Article 1L (the North Carolina Telemedicine Practice Act) and the NC Medical Board Position Statement 5.1.4 on Telemedicine. The Board's position is relatively permissive: an evaluation "need not be in-person" if the provider uses technology sufficient to meet the standard of care. This is a standard-of-care standard, not a hard in-person mandate.

North Carolina does not require a mandatory in-person visit before prescribing controlled substances via telehealth, as long as the standard of care is met. For controlled substances including testosterone (Schedule III), providers must comply with DEA rules and use the NC Controlled Substances Reporting System (the state PDMP). The DEA extension through December 31, 2026 allows Schedule II through V prescribing via telehealth without a prior in-person visit.

COVID-era telehealth expansions were maintained through NC DHHS administrative policy rather than a single comprehensive bill. NC Medicaid expanded telehealth permanently through internal policy changes. The NCMB position statement does not require in-person visits, which is effectively permanent. There is no single "permanent telehealth expansion" bill equivalent to Ohio's HB 122. NC Session Law 2023-7 (HB 76) touched telehealth but primarily focused on Medicaid expansion and certificate of need reforms.

North Carolina joined the IMLC in the 2025-2026 period, with the NC Medical Board processing IMLC applications as of January 1, 2026. This is a recent addition that should improve provider availability going forward.

One restriction that matters for telehealth: NC law (G.S. 90-85.26) requires that controlled substances be dispensed by a pharmacy licensed in North Carolina. Out-of-state compounding pharmacies shipping Schedule III controlled substances (including testosterone) to NC patients must hold NC Board of Pharmacy nonresident pharmacy licensure. This is a fulfillment-side restriction that affects some telehealth providers.

North Carolina has 10.4 million residents and is the ninth-largest state. Provider availability is good, bolstered by the recent IMLC membership. Of the 64 providers tracked, roughly 53 serve North Carolina.

Feel30 excludes North Carolina for TRT. The likely reason is the NC pharmacy licensure requirement: out-of-state compounding pharmacies shipping testosterone (Schedule III) into NC must hold an NC Board of Pharmacy nonresident pharmacy license. Feel30, based in Austin, may use a compounding pharmacy without NC licensure. Their enclomiphene service, which is not a controlled substance, covers all 50 states.

Providers that serve NC for TRT include Maximus ($100/mo, all 50 states), Hone Health ($25/mo, all 50 states), TRT Nation ($99/mo, serves 45 states including NC), BraverX ($129/mo), PeterMD ($99/mo annual), DudeMeds ($77/mo), and Titan Medical ($99/mo). Defy Medical and Marek Health also serve "Most US states."

GLP-1 availability is unrestricted. No semaglutide or tirzepatide state-level restrictions apply. Embody, SkinnyRx, DirectMeds, Remedy Meds, GobyMeds, Sesame Care, Shed, MEDVi, Sunlight, and Mochi Health all serve North Carolina. NC is notable for being one of the few states where Medicaid covers GLP-1s for weight loss (reinstated December 2025).

All HRT, hair loss, and ED providers serve the state. Enhance MD does not appear to exclude NC. Strut Health excludes only Alaska.

TRT pricing matches national rates. DudeMeds: $77/mo ($1,124/year). TRT Nation: $99/mo ($1,446/year). PeterMD: $99/mo annual ($1,188/year with labs). Maximus: $100/mo annual ($1,300/year). Titan Medical: $99/mo ($1,417/year). BraverX: $129/mo ($1,548/year). Defy Medical: $200/mo ($2,800/year). Feel30 ($99/mo, $1,188/year) is not available in NC for TRT.

GLP-1 ranges from $99/mo to $399/mo, same as the national spread. GobyMeds at $119/mo and Fridays at $117/mo are budget options.

North Carolina Medicaid has a complex recent history with GLP-1 coverage. NC Medicaid added coverage for FDA-approved obesity medications (Wegovy, Zepbound, Saxenda) for patients 12 and older effective August 1, 2024. Coverage was discontinued October 1, 2025 due to funding. Coverage was reinstated effective December 12, 2025 by Governor's directive. As of April 2026, Wegovy is the preferred drug on the formulary. Zepbound and Saxenda are non-preferred and require step therapy (failure of Wegovy first). Prior authorization is required. NC is one of the few states currently covering weight-loss GLP-1s through Medicaid.

North Carolina does not tax prescription medications. The state sales tax is 4.75% (plus local) but does not apply to Rx drugs.

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo), Alloy ($49/mo). ED: Hims $17/mo to MEDVi $119/mo.

TRT (testosterone replacement therapy)

NC Medical Board Position Statement 5.1.4 does not mandate an in-person visit. Standard-of-care evaluation via telehealth is sufficient. Testosterone (Schedule III) is prescribable via telehealth. The NC pharmacy licensure requirement (G.S. 90-85.26) means out-of-state compounding pharmacies must hold NC Board of Pharmacy nonresident licensure to ship testosterone to NC patients. This is why Feel30 excludes NC. Both compounded and FDA-approved testosterone are available from providers with compliant pharmacy networks.

GLP-1 weight loss

No state-specific restrictions on semaglutide or tirzepatide. Federal FDA compounding rules apply. NC Medicaid covers Wegovy (preferred), Zepbound, and Saxenda (non-preferred, step therapy required) for patients 12+ with prior authorization. This is unusual among states and a significant benefit for NC Medicaid members seeking GLP-1 weight loss treatment.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in North Carolina. No additional state restrictions apply. All HRT providers serve the state.

Hair loss

Hair loss treatment follows standard federal prescribing rules in North Carolina. No additional state restrictions apply.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in North Carolina. No additional state restrictions apply.

Peptides

Peptide therapy follows standard federal rules. The NC pharmacy licensure requirement for controlled substances extends to compounded peptides that contain scheduled ingredients. Sermorelin, BPC-157, and NAD+ are available from Maximus and Defy Medical.